AAAAAA

   
Results: 1-25 | 26-40 |
Results: 26-40/40
Digital rectal examination and mortality from prostate cancer - Reply by the authors
Authors: Jacobsen, SJ Bergstralh, EJ Katusic, SK Guess, HA Darby, CH Silverstein, MD Oesterling, JE Lieber, MM
Citation: Sj. Jacobsen et al., Digital rectal examination and mortality from prostate cancer - Reply by the authors, UROLOGY, 53(4), 1999, pp. 864-864
Impact of primary surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989
Authors: Hay, ID Bergstralh, EJ Grant, CS McIver, B Thompson, GB van Heerden, JA Goellner, JR
Citation: Id. Hay et al., Impact of primary surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989, SURGERY, 126(6), 1999, pp. 1173-1181
Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alonefor pTxN+ prostate cancer: A matched comparison
Authors: Ghavamian, R Bergstralh, EJ Blute, ML Slezak, J Zincke, H
Citation: R. Ghavamian et al., Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alonefor pTxN+ prostate cancer: A matched comparison, J UROL, 161(4), 1999, pp. 1223-1227
Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alonefor pTxN+ prostate cancer: A matched comparison - Reply
Authors: Ghavamian, R Bergstralh, EJ Blute, ML Slezak, J Zincke, H
Citation: R. Ghavamian et al., Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alonefor pTxN+ prostate cancer: A matched comparison - Reply, J UROL, 161(4), 1999, pp. 1227-1228
Androgen receptor expression in prostatic intraepithelial neoplasia and cancer
Authors: Sweat, SD Pacelli, A Bergstralh, EJ Slezak, JM Bostwick, DG
Citation: Sd. Sweat et al., Androgen receptor expression in prostatic intraepithelial neoplasia and cancer, J UROL, 161(4), 1999, pp. 1229-1232
Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery
Authors: Sweat, SD Pacelli, A Bergstralh, EJ Slezak, JM Cheng, L Bostwick, DG
Citation: Sd. Sweat et al., Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery, J UROL, 161(4), 1999, pp. 1233-1237
Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted county, Minnesota
Authors: Roberts, RO Bergstralh, EJ Katusic, SK Lieber, MM Jacobsen, SJ
Citation: Ro. Roberts et al., Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted county, Minnesota, J UROL, 161(2), 1999, pp. 529-533
Correlation of margin status and extraprostatic extension with progressionof prostate carcinoma
Authors: Cheng, L Darson, MF Bergstralh, EJ Slezak, J Myers, RP Bostwick, DG
Citation: L. Cheng et al., Correlation of margin status and extraprostatic extension with progressionof prostate carcinoma, CANCER, 86(9), 1999, pp. 1775-1782
Dedifferentiation in the metastatic progression of prostate carcinoma
Authors: Cheng, L Slezak, J Bergstralh, EJ Cheville, JC Sweat, S Zincke, H Bostwick, DG
Citation: L. Cheng et al., Dedifferentiation in the metastatic progression of prostate carcinoma, CANCER, 86(4), 1999, pp. 657-663
p53 protein overexpression is associated with increased cell proliferationin patients with locally recurrent prostate carcinoma after radiation therapy
Authors: Cheng, L Sebo, TJ Cheville, JC Pisansky, TM Slezak, J Bergstralh, EJ Pacelli, A Neumann, RM Zincke, H Bostwick, DG
Citation: L. Cheng et al., p53 protein overexpression is associated with increased cell proliferationin patients with locally recurrent prostate carcinoma after radiation therapy, CANCER, 85(6), 1999, pp. 1293-1299
Predictors of cancer progression in T1a prostate adenocarcinoma
Authors: Cheng, L Bergstralh, EJ Scherer, BG Neumann, RM Blute, ML Zincke, H Bostwick, DG
Citation: L. Cheng et al., Predictors of cancer progression in T1a prostate adenocarcinoma, CANCER, 85(6), 1999, pp. 1300-1304
p53 alteration in regional lymph node metastases from prostate carcinoma -A marker for progression?
Authors: Cheng, L Leibovich, BC Bergstralh, EJ Scherer, BG Pacelli, A Ramnani, DM Zincke, H Bostwick, DG
Citation: L. Cheng et al., p53 alteration in regional lymph node metastases from prostate carcinoma -A marker for progression?, CANCER, 85(11), 1999, pp. 2455-2459
Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease
Authors: O'Sullivan, DA Torres, VE Gabow, PA Thibodeau, SN King, BF Bergstralh, EJ
Citation: Da. O'Sullivan et al., Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease, AM J KIDNEY, 32(6), 1998, pp. 976-983
Cancer volume of lymph node metastasis predicts progression in prostate cancer
Authors: Cheng, L Bergstralh, EJ Cheville, JC Slezak, J Corica, FA Zincke, H Blute, ML Bostwick, DG
Citation: L. Cheng et al., Cancer volume of lymph node metastasis predicts progression in prostate cancer, AM J SURG P, 22(12), 1998, pp. 1491-1500
Unilateral total lobectomy: Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?
Authors: Hay, ID Grant, CS Bergstralh, EJ Thompson, GB van Heerden, JA Goellner, JR
Citation: Id. Hay et al., Unilateral total lobectomy: Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?, SURGERY, 124(6), 1998, pp. 958-964
Risultati: 1-25 | 26-40 |